You have 9 free searches left this month | for more free features.

Umbilical Cord Blood Regulatory T Lymphocyte

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type1 Diabetes, Autoimmune Diabetes Trial in Changsha (Liraglutide, UCB-Treg, Insulin)

Recruiting
  • Type1 Diabetes Mellitus
  • Autoimmune Diabetes
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

Diabetes, Type 1 Trial in Changsha (Umbilical Cord Blood Regulatory T cells Therapy, Insulin)

Recruiting
  • Diabetes Mellitus, Type 1
  • Umbilical Cord Blood Regulatory T cells Therapy
  • Insulin
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)

Recruiting
  • Diabetes Mellitus, Type 1
  • Immunologic Deficiency Syndromes
  • Sequential transplantation
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Aug 4, 2022

Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • CK0803
  • Excipient
  • New York, New York
    Columbia University Irving Medical Center
Jan 26, 2023

Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)

Recruiting
  • Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
  • Human T Lymphoid Progenitor (HTLP) injection
  • Pessac, France
  • +1 more
Oct 28, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

Completed
  • Acute Biphenotypic Leukemia
  • +6 more
  • Aurora, Colorado
  • +2 more
Jan 12, 2022

COVID19, ARDS Trial in United States (CK0802, Placebo)

Completed
  • COVID19
  • ARDS
  • CK0802
  • Placebo
  • Baltimore, Maryland
  • +4 more
Mar 8, 2022

Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

Available
  • Hematologic Malignancies
  • +2 more
  • CliniMACS CD34 Reagent System
  • Durham, North Carolina
    Duke University Medical Center
Nov 12, 2021

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

Recruiting
  • Acute Graft Versus Host Disease
  • MSCTC-0010 Dose Escalation
  • Kansas City, Kansas
    Kansas University Cancer Center
Jan 30, 2023

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)

Completed
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2021

Acute Myelocytic Leukemia Trial in Hefei (Unrelated umbilical cord blood, Venetoclax, Decetabine)

Recruiting
  • Acute Myelocytic Leukemia
  • Unrelated umbilical cord blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Umbilical Cord Abnormalities in Prediction of Adverse Pregnancy

Not yet recruiting
  • Small for Gestational Age at Delivery
  • +3 more
  • Umbilical cord measurements & observations
  • (no location specified)
Jun 5, 2023

Umbilical Cord Milking Trial in Alexandria (Delayed cord clamping for 30 seconds)

Completed
  • Umbilical Cord Milking
  • Delayed cord clamping for 30 seconds
  • Alexandria, Egypt
    Tamer Ahmed Hosny
Jul 20, 2023

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Guillain-Barré Syndrome Trial (CK0801)

Withdrawn
  • Guillain-Barré Syndrome
  • CK0801
  • (no location specified)
Jan 3, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Three-dimensional Umbilical Cord Coiling Index

Not yet recruiting
  • Umbilical Cord Issue
  • +2 more
  • Ultrasound
  • Nahariya, Hazafon, Israel
    Galilee Medical Center
Feb 4, 2023

Ischemic Heart Disease Trial in Miami, Louisville, Houston (umbilical cord-derived mesenchymal stromal cells (UC-MSCs))

Not yet recruiting
  • Ischemic Heart Disease
  • umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
  • Miami, Florida
  • +2 more
Nov 17, 2023

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023